Performace of Genotype-MTBDR Test Directly on Clinical Specimens

Abstract

Objectives: Most important point for the control and effective treatment of multidrug resistant tuberculosis (MDR-TB) is early diagnosis and rapid determination of the resistance. The aim of this study is to assess the performance of the Genotype-MTBDR assay applied directly on sputum samples and compare the results with those obtained by DNA sequencing and phenotypic susceptibility testing. Materials and methods: Between November 2005 and February 2006, 93 smear and culture positive sputum samples were included in the study. Drug susceptibility results for rifampin (RIF) and isoniazid (INH), obtained by proportion method on L-J medium, Genotype-MTBDR and DNA sequencing were compared. Results: The rate of concordance between the results of the Genotype-MTBDR and DNA sequencing was 93.5% and 96.7% for RIF and INH, respectively. Moreover, Genotype-MTBDR detected all the RIF (24) and INH (18) resistant strains obtained by sequencing (100%). Compared to the DNA sequencing method; the sensitivity, specificity, positive predictive and negative predictive value for RIF and INH were 100%, 91.3%, 80%, 100% and 100%, 96%, 85.7%, 100% respectively. Conclusion: Genotype-MTBDR, one of molecular assays, distinctly shortens the time for diagnosis and detection of resistance to INH and RIF, essential for management of MDR-TB. The test appears to have good sensitivity and specificity when also used directly on sputum specimens.

Keywords

• -

Performace of Genotype-MTBDR Test Directly on Clinical Specimens

Öz

Anahtar Kelimeler

• -

References

1. Bang D, Andersen AB, Thomsen VO. Rapid Genotypic De- tection of Rifampin and Isoniazid Resistant Mycobacterium tuberculosis Directly in Clinical Specimens. J Clin Microbiol 2006; 44: 2605-2608.
2. Wide MM, Zhang Y. Mechanism of Drug Resisance in My- cobacterium tuberculosis. Frontiers in Bioscience 2004; 9: 975-992.
3. World Health Organization. New Laboratory Diagnostic Tools for Tuberculosis Control. 2008.
4. Çöplü N. Duyarlılık testlerinde Löwenstein-Jensen Besiyeri Kullanımının Avantajları, Dezavantajları, Kullanılan Ülkeler. S:175-180. In:Ulusal Mikobakteri Simpozyumu Kongre Kitabı 2004 (Turkish).
5. Zhang Y, Telenti A. Genetics of drug resistance in Mycobacte- rium tuberculosis. In: Hatfull GF, Jacobs WR Jr, Eds. Molecu- lar genetics of mycobacteria. Washington DC: ASM Press; 2000. 235-251.
6. Zhang Y, Yew WW. Mechanisms of drug resistance in Myco- bacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13:1320- 1330.
7. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of My- cobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40: 4435-4438.
8. Cavusoglu C, Turhan A, Akıncı P, Soyler I. Evaluation of the Genotype-MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Iso- lates. J Clin Microbiol 2006; 44: 2338-2342.

9. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the Genotype-MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. J Clin Microbiol 2005; 43: 3699-3703.
10. Makinen J, Marttila HJ, Marjamaki M, Vijanen MK, Soini H. Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-352.
11. Miotto P, Piana F, Cirillo DM. Genotype-MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacte- rium tuberculosis. J Clin Microbiol 2007; 46:393-394.
12. Nikolayevskyy V, Balabanova Y, Simak T, Nadezhda M, Fedorin I, Drobniewski F. Performance of the Genotype- MTBDRplus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol 2009; 10 (9): 2.
13. Çavuşoğlu C, Gürsel D, Bozkurt Aktoprak H. Evaluation of the Genotype- MTBDRplus assay for the diagnosis of tuberculo- sis and rapid detection of rifampin and isoniazid resistance in clinical specimens. Turk J Med Sci 2011; 41(3):419-425.
14. Gümüşlü F, Ceyhan İ, Kocagöz T, Sonmez N. Tüberküloz La- boratuvar Rehberi. 1.Baskı. T.C. Sağlık Bakanlığı Refik Say- dam Hıfzıssıhha Merkez Başkanlığı, Ankara 1998 (Turkish).
15. Schilke K, Weyer K, Bretzel G, et al. Universal pattern of rpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa. Int J Tuber Lung Dis 1999; 3: 620-626.
16. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfin- ger M. Use of smear- positive samples to assess the PCR- based Genotype-MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its re- sistance to isoniazid and rifampin. J Clin Microbiol 2006; 44: 4459-4463.
17. World Health Organization. Multidrug and extensively drug- resistant TB (M/XDR-TB). 2010 Global Report on surveil- lance and response. 2010.
18. Pia M., Ramsay A., O’Brien R. Evidence based tuberculosis diagnosis. PLOS Medicine 2008; 5(7), doi:10.1371/journal. pmed.0050156.
19. Yolsal N, Malat G, Dişçi R, Orkun M, Kiliçaslan Z. Türkiye’de Tüberküloz İlaçlarına Direnç Sorununun 1984-1989 ve 1990- 1995 yılları için Karşılaştırılması: Meta analiz. KLİMİK Dergi- si 1998; 11: 69 (in Turkish).
20. Kısa O, Albay A, Baylan O, Balkan A, Doğancı L. Drug Re- sistance in Mycobacterium. Tuberculosis: A Retrospective Study from a 2000-Bed Teaching Hospital in Ankara, Turkey. International Journal of Antimicrobial Agents 2003; 22: 457- 467.
21. Oztürk CE, Sanic A, Kaya D, Ceyhan İ. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobac- terium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. J Infect Dis 2005; 58: 309-312.
22. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the Genotype-MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low and High-Level Re- sistance. J Clin Microbiol 2006; 44: 3659-3664.
23. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of Genotype-MTBDR assay for molecular detec- tion of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006; 44: 2485-2491.
24. Rinder H, Mieskes KT, Loscher T. Heteroresistance in Myco- bacterium tuberculosis. Int J Tuberc Lung Dis 2001; 5: 339- 345.
25. Avkan OV, Eroglu C, Guneri S, et al. RpoB gene mutations in rifampin resistant Mycobacterium tuberculosis strains iso- lated in Aegean region of Turkey. J Chemother 2004; 16: 442-445.
26. Aktas E, Durmaz R, Yang D, Yang Z. Molecular Characteriza- tion of Isoniazid and Rifampin Resistance of Mycobacterium tuberculosis Clinical Isolates from Malatya, Turkey. Microbial Drug Resistanc 2005; 11: 94-99.
27. Karahan ZC, Atalay F, Uzun M, Erturan Z, Atasever M, Akar N. Sequence analysis of rpoB mutations in rifampin resistant clinical Mycobacterium tuberculosis isolates from Turkey. Mi- crob Drug Resist 2004; 10: 325-333.
28. Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-23.
29. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele specific rpoB PCR assays for detection of rifampin resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother 2003; 47: 2231-2235.
30. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampinresistant Mycobacterium tuberculosis strains iso- lated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 1999; 37: 2663-2666.
31. Ahmad S, Araj GF, Akbar PK, Fares E, Chugh TD, Mustafa AS. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn Microbiol Infect Dis 2000; 38: 227-232.
32. Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuber- culosis isolates from Kuwait and Dubai. Diagn Microbiol In- fect Dis 2002; 44: 245-252.
33. Abal AT, Ahmad S, Mokaddas E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid- resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist 2002; 8: 99-105.